The approval allows for the sale of SCENARIA on the Canadian market.
SCENARIA offers dose efficiencies, excellent image quality and enhanced workflow to meet the needs of a wider range of imaging environments, Hitachi Medical said.
Hitachi Medical Systems America markets advanced diagnostic medical imaging systems of Japanese Hitachi Medical Corp across the US.
Horizon Medical Services develops diagnostic solutions including digital x-ray, nuclear medicine, ultrasound, CT, and MRI for hospital and clinic environments throughout North America.
Kexing Biopharm begins enrolment for Phase I trial of GB10 in China
Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma
Pharming secures FDA acceptance of Joenja filing for children with APDS
UCB and Biogen present Phase 3 data highlighting potential of dapirolizumab pegol in lupus treatment
Persist AI partners with Microsize and Micromacinazione to launch drug formulation platform
RedHill Biopharma advancing opaganib options for Ebola outbreak
Sun Pharma receives American Skin Association 2026 Corporate Leadership Award
Evogene completes Phase 1 study of BMC128 in combination with Nivolumab